VISTIN PHARMA ASA
Operating
Utvikling, produksjon og salg av legemidler og andre helserelaterte
produkter og tjenester. Dette kan også realiseres ved eierskap i andre
selskaper.
Keywords
productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings
Links
Organization
- CEO
- Chairman of the board
- ØA
- Years since formation
- 11 years
- since Mar 24, 2015
- Type
- Public limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 44,344,592
- 1 share class
- Total number of shareholders
- 1929
- 178 companies, 1,751 persons
- Belongs to group of
Financials
- Annual total result 2024
- -3,526,000
- NOK
- Total equity 2024
- 184,035,000
- NOK
Last update: Dec 12, 2025
Locations
- Company addressØstensjøveien 27 0661 OSLO, Norge
Copied! - Postal addressPostboks 6735 Etterstad 0609 OSLO, Norge
Copied!
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
ØA | Chairman | 9.65 % indirectly |
EL | Board Member | - |
BB 1972 | Board Member | - |
| Board Member | - | |
KE | Board Member | - |
SW | Board Member | - |
AK 1971 | Alternate Member | - |
KP | Alternate Member | - |
GA | Alternate Member | - |
SI 1974 | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
E ERNST & YOUNG AS | Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
ØA | Chairman | 9.65 % indirectly |
CB 1975 | - | 9.35 % indirectly |
AB 1978 | - | 9.35 % indirectly |
ØS | - | 4.28 % directly 0.73 % indirectly 3.55 % |
| - | 2.38 % indirectly | |
| - | 1.99 % indirectly | |
| - | 1.77 % directly 0.08 % indirectly 1.69 % | |
KA 1952 | - | 1.67 % directly 0.05 % indirectly 1.62 % |
HM | - | 1.59 % directly |
KG | - | 1.22 % indirectly |
Last update: Dec 19, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
I INTERTRADE SHIPPING AS | NO0010734122 | 12,575,000 | 28.36 % |
H HOLMEN SPESIALFOND | NO0010734122 | 4,200,379 | 9.47 % |
P PACTUM VEKST AS | NO0010734122 | 2,991,773 | 6.75 % |
M MP PENSJON PK | NO0010734122 | 1,719,848 | 3.88 % |
F FERNCLIFF LISTED DAI AS | NO0010734122 | 1,234,280 | 2.78 % |
S STORKLEIVEN AS | NO0010734122 | 751,000 | 1.69 % |
A AUGUST RINGVOLD AGENTUR AS | NO0010734122 | 750,315 | 1.69 % |
L LUCELLUM AS | NO0010734122 | 720,000 | 1.62 % |
HM | NO0010734122 | 706,253 | 1.59 % |
S SAGA PURE ASA | NO0010734122 | 700,000 | 1.58 % |
T TIGERSTADEN AS | NO0010734122 | 540,170 | 1.22 % |
I IVAR LØGES STIFTELSE | NO0010734122 | 540,000 | 1.22 % |
S SURFSIDE HOLDING AS | NO0010734122 | 527,960 | 1.19 % |
| NO0010734122 | 519,324 | 1.17 % | |
C CORTEX AS | NO0010734122 | 508,989 | 1.15 % |
S SANDEN EQUITY AS | NO0010734122 | 500,000 | 1.13 % |
| NO0010734122 | 500,000 | 1.13 % | |
D DELTA AS | NO0010734122 | 410,000 | 0.92 % |
G GINKO AS | NO0010734122 | 400,000 | 0.9 % |
W WEM INVEST AS | NO0010734122 | 395,000 | 0.89 % |
ØS | NO0010734122 | 323,650 | 0.73 % |
M MELESIO INVEST AS | NO0010734122 | 309,808 | 0.7 % |
NC | NO0010734122 | 301,658 | 0.68 % |
NA | NO0010734122 | 284,040 | 0.64 % |
F FRENICO AS | NO0010734122 | 215,000 | 0.48 % |
NM 1950 | NO0010734122 | 213,000 | 0.48 % |
O OVÅ INVEST AS | NO0010734122 | 200,000 | 0.45 % |
H HJELLEGJERDE INVEST AS | NO0010734122 | 200,000 | 0.45 % |
T TRULS INVEST AS | NO0010734122 | 200,000 | 0.45 % |
F Fraternitas A/S | NO0010734122 | 180,000 | 0.41 % |
U UNIVERSAL EXPORTS AS | NO0010734122 | 180,000 | 0.41 % |
T TRACK AS | NO0010734122 | 179,087 | 0.4 % |
S SOGNEFJELL AS | NO0010734122 | 174,529 | 0.39 % |
H HEKAMA INVEST AS | NO0010734122 | 153,440 | 0.35 % |
F FATEBURET AS | NO0010734122 | 149,800 | 0.34 % |
A AGDES INVEST AS | NO0010734122 | 140,000 | 0.32 % |
KE | NO0010734122 | 140,000 | 0.32 % |
| NO0010734122 | 137,570 | 0.31 % | |
| NO0010734122 | 131,919 | 0.3 % | |
G GSH INVEST AS | NO0010734122 | 131,000 | 0.3 % |
F FOLLUM CAPITAL AS Closed | NO0010734122 | 128,000 | 0.29 % |
| NO0010734122 | 125,000 | 0.28 % | |
JK | NO0010734122 | 124,667 | 0.28 % |
SA 1949 | NO0010734122 | 115,003 | 0.26 % |
G GK INVEST HOLDING AS | NO0010734122 | 115,000 | 0.26 % |
J JOTUNFJELL AS | NO0010734122 | 110,076 | 0.25 % |
N NORDNET LIVSFORSIKRING AS | NO0010734122 | 105,468 | 0.24 % |
L LUUNA AS | NO0010734122 | 100,264 | 0.23 % |
B BELA AS | NO0010734122 | 100,000 | 0.23 % |
N NORUMBEGA AS | NO0010734122 | 100,000 | 0.23 % |
B BELE AS | NO0010734122 | 100,000 | 0.23 % |
KO 1962 | NO0010734122 | 100,000 | 0.23 % |
F FJORD HOLDING AS | NO0010734122 | 98,686 | 0.22 % |
H HAFSTAD INVEST AS | NO0010734122 | 96,000 | 0.22 % |
A AALL KAPITAL AS | NO0010734122 | 92,694 | 0.21 % |
JE | NO0010734122 | 88,506 | 0.2 % |
ML 1946 | NO0010734122 | 87,000 | 0.2 % |
H HARMOHNI AS | NO0010734122 | 85,000 | 0.19 % |
K KULA INVEST AS | NO0010734122 | 84,850 | 0.19 % |
M MUSTADGÅRDENE HOLDING AS | NO0010734122 | 81,777 | 0.18 % |
FS 1968 | NO0010734122 | 81,200 | 0.18 % |
H HGD INVEST AS | NO0010734122 | 78,273 | 0.18 % |
VR | NO0010734122 | 77,360 | 0.17 % |
C CHRISHØEG AS | NO0010734122 | 75,875 | 0.17 % |
| NO0010734122 | 75,000 | 0.17 % | |
T TRINITY GROUP AS | NO0010734122 | 70,000 | 0.16 % |
BA | NO0010734122 | 69,106 | 0.16 % |
HA | NO0010734122 | 64,274 | 0.14 % |
PW 1943 | NO0010734122 | 62,000 | 0.14 % |
TE | NO0010734122 | 60,000 | 0.14 % |
FM | NO0010734122 | 60,000 | 0.14 % |
OS 1962 | NO0010734122 | 59,051 | 0.13 % |
A AEL INVEST AS | NO0010734122 | 55,000 | 0.12 % |
AJ | NO0010734122 | 53,109 | 0.12 % |
KE | NO0010734122 | 52,995 | 0.12 % |
M MAGNUS DEN GODE AS | NO0010734122 | 51,586 | 0.12 % |
| NO0010734122 | 50,952 | 0.11 % | |
GK | NO0010734122 | 50,120 | 0.11 % |
ØS 1935 | NO0010734122 | 50,000 | 0.11 % |
L LAL HOLDING AS | NO0010734122 | 50,000 | 0.11 % |
LP | NO0010734122 | 50,000 | 0.11 % |
O ORAKEL AS | NO0010734122 | 50,000 | 0.11 % |
A AASE INVESTERING AS | NO0010734122 | 50,000 | 0.11 % |
AL | NO0010734122 | 50,000 | 0.11 % |
SR 1961 | NO0010734122 | 50,000 | 0.11 % |
| NO0010734122 | 48,141 | 0.11 % | |
S STRIN AS | NO0010734122 | 45,000 | 0.1 % |
BL 1951 | NO0010734122 | 44,573 | 0.1 % |
DK | NO0010734122 | 44,133 | 0.1 % |
S SKALLUM AS | NO0010734122 | 43,000 | 0.1 % |
| NO0010734122 | 42,744 | 0.1 % | |
A ALF MARTINSEN INVEST AS | NO0010734122 | 42,388 | 0.1 % |
2 2M-INVEST AS | NO0010734122 | 40,500 | 0.09 % |
ET 1955 | NO0010734122 | 40,089 | 0.09 % |
AK 1961 | NO0010734122 | 40,000 | 0.09 % |
O OED INVEST AS | NO0010734122 | 40,000 | 0.09 % |
JH 1951 | NO0010734122 | 40,000 | 0.09 % |
BA | NO0010734122 | 40,000 | 0.09 % |
HM | NO0010734122 | 40,000 | 0.09 % |
BM | NO0010734122 | 40,000 | 0.09 % |
Shares owned by the VISTIN PHARMA ASA
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
V VISTIN PHARMA AS | Ordinary shares | 50,000 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -6,052,000Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -3,526,000 | -2,984,000 | -1,852,000 | -2,558,000 |
Total assets | 186,589,000 | 266,244,000 | 269,084,000 | 277,810,000 |
Total liabilities | 2,554,000 | 1,096,000 | 953,000 | 7,829,000 |
Total equity | 184,035,000 | 265,148,000 | 268,132,000 | 269,983,000 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 6,052,000 | 6,978,000 | 4,194,000 | 4,698,000 |
Operating result | -6,052,000 | -6,978,000 | -4,194,000 | -4,698,000 |
Financial income/costs | 1,532,000 | 3,152,000 | 1,820,000 | 1,419,000 |
Profit before tax | -4,520,000 | -3,826,000 | -2,374,000 | -3,279,000 |
Total tax & extraordinary income/cost | -994,000 | -842,000 | -522,000 | -721,000 |
Annual Total Result | -3,526,000 | -2,984,000 | -1,852,000 | -2,558,000 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 54,857,000 | 113,113,000 | 108,112,000 | 107,590,000 |
Total current assets | 131,732,000 | 153,131,000 | 160,972,000 | 170,220,000 |
Total assets | 186,589,000 | 266,244,000 | 269,084,000 | 277,810,000 |
Short term debt | 2,554,000 | 1,096,000 | 953,000 | 7,829,000 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 2,554,000 | 1,096,000 | 953,000 | 7,829,000 |
Contributed capital | 184,035,000 | 265,148,000 | 268,132,000 | 269,983,000 |
Retained earnings | 0 | 0 | 0 | 0 |
Total equity | 184,035,000 | 265,148,000 | 268,132,000 | 269,983,000 |
Total equity and liabilities | 186,589,000 | 266,244,000 | 269,085,000 | 277,812,000 |
Classification
21st company classification
BETA
Scaleup
Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations